NAII

Business Context and Reporting Period

Company: Natural Alternatives International, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 1997 (First Quarter of Fiscal 1998)
Business Overview: The Company operates in the health and wellness sector, including multi-level distribution. Operations include wholly-owned subsidiaries (Millennium Health International, CellLife International, and CellLife Pharmaceuticals) which were consolidated into the parent company during fiscal 1997. A new tablet manufacturing facility was ramped up during the period.

Key Financial Metrics

Note: Working Capital calculated as Total Current Assets ($16,892,123) minus Total Current Liabilities ($5,760,709). Q1 1997 working capital derived from prior period balance sheet data.

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased by approximately 5.2% ($595,554) compared to the prior year quarter. This was driven by the ramp-up of a new tablet manufacturing facility and increased international sales ($3.6 million vs. $0.3 million in the prior year).
• Profitability Decline: Despite higher sales, Net Earnings decreased by 33.5% ($301,953). Gross margins contracted from 28.5% to 26.3% due to increased raw material costs and subcontracted packaging expenses.
• Expense Increase: Selling, general, and administrative (SG&A) expenses rose by $458,729 (from $1.75M to $2.21M), representing an increase from 15.3% to 18.3% of revenue. This was primarily due to the adoption of a new defined benefit pension plan and depreciation/start-up costs for the new facility.
• Cash Flow: Net cash provided by operating activities turned negative at $(229,033), compared to positive $240,668 in the prior year. This was driven by a $1.38 million increase in inventory and a $1.6 million decrease in accounts payable, partially offset by a $1.24 million decrease in accounts receivable.

Outlook, Risks, and Management Commentary

• Liquidity: The Company maintains a $3,000,000 revolving line of credit secured by receivables, inventory, and equipment. No borrowings were outstanding under this line as of September 30, 1997. Management expects to fund future capital expenditures (approx. $600,000 for equipment) through operating cash flow and existing credit facilities.
• Customer Concentration Risk: Five major customers accounted for 78% of total sales in the quarter. The loss of any single major customer could have an adverse impact on revenues.
• Legal Proceedings: The Company is involved in various ordinary course legal actions, but management does not anticipate a material adverse impact on financial position.
• Forward-Looking Statements: Management notes that actual results may differ from projections due to risks discussed in the Form 10-K.

Investor Verification Checklist

• Inventory Build-up: Verify the necessity of the $1.38 million increase in inventory against the reported sales order backlog to ensure no obsolescence risk.
• Customer Dependency: Assess the stability of the top five customers who represent 78% of revenue, particularly given the concentration in the multi-level distribution segment.
• Margin Pressure: Monitor raw material costs and subcontracting fees to determine if the 26.3% gross margin is sustainable or if further compression is likely.
• Cash Flow Sustainability: Review the negative operating cash flow trend to ensure the company can meet its $600,000 equipment commitment and debt obligations without drawing on the credit line.
• Pension Obligations: Confirm the long-term funding requirements of the new defined benefit pension plan adopted in January 1997.